ITeos Therapeutics Inc (ITOS)
10.59
-0.42
(-3.81%)
USD |
NASDAQ |
Apr 24, 16:00
10.59
0.00 (0.00%)
After-Hours: 20:00
ITeos Therapeutics Total Liabilities (Quarterly): 92.36M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 92.36M |
| September 30, 2023 | 79.38M |
| June 30, 2023 | 80.22M |
| March 31, 2023 | 76.08M |
| December 31, 2022 | 91.66M |
| September 30, 2022 | 143.67M |
| June 30, 2022 | 177.47M |
| March 31, 2022 | 223.94M |
| December 31, 2021 | 331.89M |
| Date | Value |
|---|---|
| September 30, 2021 | 550.34M |
| June 30, 2021 | 29.19M |
| March 31, 2021 | 20.28M |
| December 31, 2020 | 21.36M |
| September 30, 2020 | 15.32M |
| June 30, 2020 | 12.16M |
| March 31, 2020 | 14.52M |
| December 31, 2019 | 66.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.16M
Minimum
Jun 2020
550.34M
Maximum
Sep 2021
119.22M
Average
79.38M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 39.38B |
| Merck & Co Inc | 69.04B |
| Arcus Biosciences Inc | 633.00M |
| IGM Biosciences Inc | 220.18M |
| Forian Inc | 32.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 667.59M |
| Shareholders Equity (Quarterly) | 575.23M |